SEP 9, 2026 · JOURNAL ARTICLE
Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer
International Journal of Molecular Sciences
In vitro mechanistic study in a single TNBC cell line suggesting synergy between two agents, lacking any in vivo validation, patient data, or clinical trial evidence to support therapeutic application.
Reported
Cell proliferation arrest80%
p-value for proliferation arrestp < 0.01